Discussing AAV-ligand Conjugates for Improved Efficacy & Distribution in CNS

Time: 9:30 am
day: Conference Day Two

Details:

  • Discussing the challenges of deep brain delivery and distribution of gene therapies
  • Overcoming these challenges with the use of AAV-ligand conjugates
  • Improving efficacy of gene therapies in the CNS

Speakers: